Hyclone 500ml US Origin FBS

Awarded Award Notice Posted Feb 14, 2017

Solicitation number: RFQ-RML-D-1834570
Agency: National Institutes of Health Department of Health and Human Services
Awarded: Mar 2, 2017 to Government Scientific Source Inc.
Set-aside: No set-aside

Opportunity facts

Contract number: HHSN272201700420P Federal contract award
NAICS code: 325413 In-Vitro Diagnostic Substance Manufacturing
PSC: Not on record
Place of performance: National Institute of Health Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated Feb 14, 2017.

Notice text

2 versions

As posted on SAM.gov.

Update #2 · Latest · Feb 14, 2017

Added: Feb 14, 2017 3:46 pm Modified: Feb 14, 2017 3:48 pmTrack Changes This notice is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and Solicitation for Commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation document will not be issued. Submit offers on RFQ-RML-D-1834570.

This solicitation is a request for quotes (RFQ).The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-95 January 19th ,2017.
The associated North American Industry Classification System (NAICS) code for this procurement is 325413 with a small business size standard of 500. This is not a total small business set aside.

The National Institute of Allergy and infectious Diseases (NIAID) is looking to acquire 60 EA bottles of Hyclone Certified US Origin Fetal Bovine Serum. Specific requirement including catalog # and quantity is provided below. Brand Name Justification is attached.

Catalog # SH30070.03 60 EACH 500ml Hyclone US Origin Fetal Bovine Serum
All bottles "MUST BE LOT # AB10203387"

Applicable shipping and warranty information must be quoted. Must be an authorized reseller. DUNS number must be present on quotation.

FOB Point shall be Destination; Bethesda, MD 20892).

Place of Performance:
(NIH/NIAID
Bethesda, MD 20892)
United States

Award will be based on the capability of the item offered to meet the above stated salient characteristics, price, past performance, delivery, warranty, and the best value to the government.

The following FAR provisions apply to this acquisition:
52.212-1 Instructions to Offerors Commercial Items (Oct 2015)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Nov 2015)
Offerors must complete annual representations and certifications on-line at http://www.sam.gov in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items
The following contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (May 2015)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Jan 2017)
FAR 52.209-2 Prohibition on Contracting with Inverted Domestic Corporations-Representation (Nov 2015)

The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html or, upon request, either by telephone or fax.

This is an open-market combined synopsis/solicitation for multiple Hyclone US Origin FBS as defined herein. The government intends to award a purchase order as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein. To facilitate the award process all quotes should include a statement regarding the terms and conditions herein as follows:
"The Terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion or addition."
OR
"The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:"
(Quoter shall list exception(s) and rationale for the exception(s).)
Submission shall be received not later than February 28th, 2017 at 4:00PM MST.

Offers may be mailed or e-mailed (Michael Barrett 903 South 4th St, Hamilton, MT 59840); Michael.barrett@nih.gov Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)

All responsible sources may submit an offer that will be considered by this Agency.
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to MICHAEL BARRETT at Michael.barrett@nih.gov.

Update #1 · Feb 14, 2017

Added: Feb 14, 2017 3:46 pm This notice is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and Solicitation for Commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation document will not be issued. Submit offers on RFQ-RML-D-1834570.

This solicitation is a request for quotes (RFQ).The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-95 January 13th ,2017.
The associated North American Industry Classification System (NAICS) code for this procurement is 325413 with a small business size standard of 500. This is not a total small business set aside.